Home/Filings/4/0001415889-24-002058
4//SEC Filing

Lukatch Heath 4

Accession 0001415889-24-002058

CIK 0001649094other

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 4:12 PM ET

Size

8.5 KB

Accession

0001415889-24-002058

Insider Transaction Report

Form 4
Period: 2024-01-29
Transactions
  • Exercise/Conversion

    Common Stock

    2024-01-29$16.00/sh+4,000$64,0009,625 total
  • Sale

    Common Stock

    2024-01-29$67.50/sh4,000$270,0005,625 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-01-294,00011,000 total
    Exercise: $16.00Exp: 2030-06-10Common Stock (4,000 underlying)
Footnotes (2)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2023.
  • [F2]Fully vested and exercisable.

Issuer

Vaxcyte, Inc.

CIK 0001649094

Entity typeother

Related Parties

1
  • filerCIK 0001596385

Filing Metadata

Form type
4
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:12 PM ET
Size
8.5 KB